April 18, 2018 / 8:09 PM / 7 months ago

BRIEF-Pear Therapeutics, Sandoz Announce Deal To Commercialize Prescription Digital Therapeutics

April 18 (Reuters) - Pear Therapeutics:

* PEAR THERAPEUTICS AND SANDOZ ANNOUNCE DEAL TO COMMERCIALIZE PRESCRIPTION DIGITAL THERAPEUTICS

* PEAR THERAPEUTICS - DEAL WITH SANDOZ, A DIVISION OF NOVARTIS, TO COMMERCIALIZE ITS TWO LEAD PRODUCTS, RESET AND RESET-O

* PEAR THERAPEUTICS SAYS DEAL INCLUDES RESEARCH AND DEVELOPMENT FUNDING, COMMERCIAL MILESTONES, AND A PROFIT SPLIT ON NET SALES OF BOTH THERAPEUTICS

* PEAR THERAPEUTICS SAYS SANDOZ WILL ASSUME RESPONSIBILITY FOR GLOBAL COMMERCIAL LAUNCH OF RESET, AND RESET-O

* PEAR THERAPEUTICS- PEAR WILL CONTINUE TO DEVELOP BOTH DIGITAL THERAPEUTICS AND WILL ALSO SUPPORT PATIENT SERVICES THROUGH ITS DIGITAL HUB SERVICE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below